BioDelivery Sciences International Inc (BDSI):企業の財務・戦略的SWOT分析

◆英語タイトル:BioDelivery Sciences International Inc (BDSI) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH4235FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

BioDelivery Sciences International Inc (BDSI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

BioDelivery Sciences International Inc (BDSI) is a specialty pharmaceutical company that develops and commercializes products in the areas of addiction medicine and pain management. The company’s marketed products include fentanyl buccal soluble solution for breakthrough cancer pain; buprenorphine/naloxone buccal film for opioid dependence; and buprenorphine buccal film for chronic pain. Its pipeline encompasses indications targeted at the treatment of chronic pain and opioid dependence. BDSI employs its proprietary BioErodible MucoAdhesive (BEMA) technology which comprises small, bioerodible polymer film used to facilitate rapid delivery a drug across the mucous membranes for time sensitive conditions. BDSI is headquartered in Raleigh, North Carolina, the US.

BioDelivery Sciences International Inc Key Recent Developments

Feb 11,2021: BioDelivery Sciences CFO Terry Coelho promoted to Executive Vice President
Nov 05,2020: BioDelivery Sciences reports strong Q3 2020 results
Nov 04,2020: BioDelivery Sciences announces appointment of Jeff Bailey as permanent CEO
Aug 05,2020: BioDelivery Sciences reports strong q2 2020 results
May 11,2020: BioDelivery Sciences appoints Jeff Bailey interim CEO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
BioDelivery Sciences International Inc – Key Facts
BioDelivery Sciences International Inc – Key Employees
BioDelivery Sciences International Inc – Key Employee Biographies
BioDelivery Sciences International Inc – Major Products and Services
BioDelivery Sciences International Inc – History
BioDelivery Sciences International Inc – Company Statement
BioDelivery Sciences International Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
BioDelivery Sciences International Inc – Business Description
Business Segment: Contract Revenue
Overview
Performance
Business Segment: Product Royalty Revenue
Overview
Performance
Business Segment: Product Sales
Overview
Performance
BioDelivery Sciences International Inc – Corporate Strategy
BioDelivery Sciences International Inc – SWOT Analysis
SWOT Analysis – Overview
BioDelivery Sciences International Inc – Strengths
BioDelivery Sciences International Inc – Weaknesses
BioDelivery Sciences International Inc – Opportunities
BioDelivery Sciences International Inc – Threats
BioDelivery Sciences International Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
BioDelivery Sciences International Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 11, 2021: BioDelivery Sciences CFO Terry Coelho promoted to Executive Vice President
Nov 05, 2020: BioDelivery Sciences reports strong Q3 2020 results
Nov 04, 2020: BioDelivery Sciences announces appointment of Jeff Bailey as permanent CEO
Aug 05, 2020: BioDelivery Sciences reports strong q2 2020 results
May 11, 2020: BioDelivery Sciences appoints Jeff Bailey interim CEO
May 07, 2020: BioDelivery Sciences reports strong Q1 2020 results
Mar 12, 2020: BioDelivery Sciences reports strong fourth quarter and full-year 2019 results
Mar 09, 2020: BioDelivery Sciences appoints Jeffrey A. Bailey to its Board of Directors
Jan 13, 2020: BioDelivery Sciences expects fourth quarter and 2019 total net sales at the high end of guidance
Jan 06, 2020: BioDelivery Sciences appoints Kevin Ostrander as Senior Vice President of Business Development
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
BioDelivery Sciences International Inc, Key Facts
BioDelivery Sciences International Inc, Key Employees
BioDelivery Sciences International Inc, Key Employee Biographies
BioDelivery Sciences International Inc, Major Products and Services
BioDelivery Sciences International Inc, History
BioDelivery Sciences International Inc, Subsidiaries
BioDelivery Sciences International Inc, Key Competitors
BioDelivery Sciences International Inc, Ratios based on current share price
BioDelivery Sciences International Inc, Annual Ratios
BioDelivery Sciences International Inc, Annual Ratios (Cont...1)
BioDelivery Sciences International Inc, Annual Ratios (Cont...2)
BioDelivery Sciences International Inc, Interim Ratios
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
BioDelivery Sciences International Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[BioDelivery Sciences International Inc (BDSI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Inventiva (IVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Inventiva is a clinical stage biopharmaceutical company that discovers and develops therapies for fibrosis, oncology and orphan diseases. The company develops pipeline products for nonalcoholic steatohepatitis, systemic sclerosis, mucopolysaccharidosis, moderate to severe psoriasis, malignan …
  • Medigen Biotechnology Corp (3176)-医療機器分野:企業M&A・提携分析
    Summary Medigen Biotechnology Corp (MBC) is a pharmaceutical company that carries out the research and development of biopharmaceuticals for the treatment of liver diseases and cancers. It focuses at developing new therapeutics, principally in the area of cancer and liver diseases. The company’s pro …
  • Hualan Biological Engineering Inc (002007):企業の財務・戦略的SWOT分析
    Summary Hualan Biological Engineering Inc (Hualan Biological) is a biopharmaceutical company that develops vaccines. The company conducts research, develops and produces plasma, vaccines and gene products. Its plasma products include surgical lyophilized fibrin sealant, human coagulation factor VIII …
  • Toronto Hydro Corporation:電力:M&Aディール及び事業提携情報
    Summary Toronto Hydro Corporation (Toronto Hydro) is a municipal electricity distribution utility. It holds businesses in electricity distribution and street lighting and expressway lighting services in Toronto. The company owns and operates electricity distribution system, which delivers electricit …
  • Sompo Holdings, Inc. (8630):企業の財務・戦略的SWOT分析
    Sompo Holdings, Inc. (8630) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Emerson Electric Co (EMR)-石油・ガス分野:企業M&A・提携分析
    Summary Emerson Electric Co. (Emerson) is a provider of infrastructure technologies and life cycle services for information and communication technology systems. The company offers hardware and software solutions for power, thermal and infrastructure management under the brands of Kop-Flex, jaure, a …
  • Perrigo Company plc:企業の戦略・SWOT・財務分析
    Perrigo Company plc - Strategy, SWOT and Corporate Finance Report Summary Perrigo Company plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Credit Guarantee Insurance Corporation of Africa Ltd:企業の戦略・SWOT・財務分析
    Credit Guarantee Insurance Corporation of Africa Ltd - Strategy, SWOT and Corporate Finance Report Summary Credit Guarantee Insurance Corporation of Africa Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's st …
  • Quaker Chemical Corp (KWR):企業の財務・戦略的SWOT分析
    Quaker Chemical Corp (KWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • VeriFone Systems Inc:企業のM&A・事業提携・投資動向
    VeriFone Systems Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's VeriFone Systems Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Nishio Rent All Co.,Ltd. (9699):企業の財務・戦略的SWOT分析
    Nishio Rent All Co.,Ltd. (9699) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • University of Texas Health Science Center at San Antonio-医療機器分野:企業M&A・提携分析
    Summary University of Texas Health Science Center at San Antonio (UTHSCSA), a subsidiary of University of Texas System is an educational university that offers undergraduate, graduate, and research programs to physicians, biomedical scientists, aging and longevity, cancer, cardiovascular, diabetes, …
  • Banco BPM S.p.A.:企業の戦略・SWOT・財務分析
    Banco BPM S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Banco BPM S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • C-Rad AB (CRAD B)-医療機器分野:企業M&A・提携分析
    Summary C-Rad AB (C-Rad) is a medical device company that develops, manufactures and markets advanced radiation therapy equipments. The company offers products and solutions for patient positioning, tumor localization, and radiation treatment systems. Its products include sentinel 4DCT, catalyst HD, …
  • Regal Petroleum plc (RPT):企業の財務・戦略的SWOT分析
    Summary Regal Petroleum Plc (Regal), a subsidiary of Energees Investments Ltd, is an oil and gas company that conducts reviews on oil and gas projects. The company operates two gas and condensate fields such as Mekhediviska - Golotovschinska and Svyrydivske located in Dneipner-Donets basin in the no …
  • Southern Maryland Electric Cooperative Inc:企業の戦略的SWOT分析
    Southern Maryland Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Depomed, Inc.:企業の戦略・SWOT・財務情報
    Depomed, Inc. - Strategy, SWOT and Corporate Finance Report Summary Depomed, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Qinetiq Group Plc
    Qinetiq Group Plc - Strategy, SWOT and Corporate Finance Report Summary Qinetiq Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Standard Bank Group Ltd (SBK):電力:M&Aディール及び事業提携情報
    Summary Standard Bank Group Ltd (SBG) is a provider of integrated financial services such as personal and business banking, corporate and investment banking, and wealth management and insurance solutions. The personal and business banking portfolio consists of transactional products, lending product …
  • RSWM Ltd. (RSWM):企業の財務・戦略的SWOT分析
    RSWM Ltd. (RSWM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆